Condition: Acinetobacter Baumannii Infection · Sponsor: Cairo University
To compare the clinical effectiveness of two different sulbactam-based regimens (ampicillin-sulbactam versus cefoperazone-sulbactam) in the treatment of Acinetobacter baumannii infections in critically ill patients.
This description comes directly from the study's public registry record.
Ayah M Khalil Ibrahem, MSc in clinical pharmacy · +20 1094748214 · dr.ayaaa@yahoo.com
Always discuss trial participation with your own doctor first.
| Cairo university hospitals kasr alainy | Cairo, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07118384